Insider Selling: Chemed (NYSE:CHE) CEO Sells $1,026,900.00 in Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, September 28th. The stock was sold at an average price of $513.45, for a total value of $1,026,900.00. Following the transaction, the chief executive officer directly owned 66,418 shares in the company, valued at approximately $34,102,322.10. This represents a 2.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Chemed Price Performance

Shares of NYSE CHE opened at $508.68 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $6.65 billion, a price-to-earnings ratio of 25.55, a price-to-earnings-growth ratio of 2.02 and a beta of 0.51. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The business has a 50 day simple moving average of $523.46 and a 200-day simple moving average of $462.31.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. During the same quarter in the previous year, the company posted $4.27 earnings per share. The firm’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities research analysts expect that Chemed Corporation will post 23.55 earnings per share for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were paid a $0.70 dividend. The ex-dividend date was Monday, August 17th. This is an increase from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a yield of 0.6%. Chemed’s payout ratio is presently 14.06%.

Analysts Set New Price Targets

CHE has been the subject of a number of recent research reports. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Wall Street Zen cut shares of Chemed from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 19th. Oppenheimer boosted their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. UBS Group assumed coverage on shares of Chemed in a research note on Friday, September 25th. They issued a “buy” rating and a $650.00 price target on the stock. Finally, Royal Bank Of Canada boosted their price objective on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Two investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $554.60.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Sequoia Financial Advisors LLC bought a new position in shares of Chemed during the 2nd quarter valued at about $563,000. Integrated Wealth Concepts LLC boosted its holdings in Chemed by 9.7% during the second quarter. Integrated Wealth Concepts LLC now owns 27,774 shares of the company’s stock worth $12,936,000 after buying an additional 2,461 shares in the last quarter. NewEdge Advisors LLC grew its position in Chemed by 4,167.3% in the second quarter. NewEdge Advisors LLC now owns 2,091 shares of the company’s stock worth $974,000 after buying an additional 2,042 shares during the last quarter. Squarepoint Ops LLC increased its holdings in shares of Chemed by 50.5% in the second quarter. Squarepoint Ops LLC now owns 5,201 shares of the company’s stock valued at $2,422,000 after buying an additional 1,745 shares in the last quarter. Finally, Baird Financial Group Inc. lifted its position in shares of Chemed by 28.8% during the 2nd quarter. Baird Financial Group Inc. now owns 1,874 shares of the company’s stock valued at $873,000 after acquiring an additional 419 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified services company headquartered in Cincinnati, Ohio. Its operations are organized through two principal businesses: VITAS Healthcare and Roto-Rooter.

VITAS Healthcare provides hospice and palliative care for patients with advanced illnesses. Its services include clinical care, pain and symptom management, emotional and spiritual support, and assistance for patients and their families in homes, hospice residences, hospitals, nursing facilities, and other care settings.